Evidence map›Paper›PMID 21826429›Full record

ArticleCurrent diabetes reports2011

Immunoisolation of pancreatic islet grafts with no recipient's immunosuppression: actual and future perspectives.

Giuseppe Basta, Riccardo Calafiore

Abstract read
PubMed Publisher
In one paragraph

Article in Current diabetes reports, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Immunoisolation of murine islet allografts in vascularized sites through conformal coating with polyethylene glycol.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2018
    Article
  3. Article
  4. Article
  5. Article
  6. Re-engineering islet cell transplantation.Pharmacological research · 2015
    Review
  7. Review
  8. Article
  9. Device design and materials optimization of conformal coating for islets of Langerhans.Proceedings of the National Academy of Sciences of the United States of America · 2014
    Article
  10. Membranes to achieve immunoprotection of transplanted islets.Frontiers in bioscience (Landmark edition) · 2014
    Review
  11. Article
  12. Article
  13. 25 YEARS OF THE RICORDI AUTOMATED METHOD FOR ISLET ISOLATION.CellR4-- repair, replacement, regeneration, & reprogramming · 2013
    Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Giuseppe BastaDepartment of Internal Medicine, Section of Internal Medicine and Endocrine and Metabolic Sciences, University of Perugia, via Enrico dal Pozzo, snc, Perugia, Italy. giuseppe.basta@unipg.it
Riccardo Calafiore

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In spite of steady and remarkable progress, islet transplantation in patients with type 1 diabetes mellitus (T1DM) continues to face two major bottlenecks: inadequate availability of human pancreatic donors and necessity to totally immunosuppress the graft recipients lifelong. Microencapsulation of the islet grafts within highly biocompatible and selective permeable biomembranes could obviate use of the immunosuppressants, while potentially offering the opportunity to use a wide array of insulin-producing cells, in active development, including xenogeneic pig islets. Although macrodevices and microcapsules, which essentially differ by size/configuration, and both serve for immunoisolation devices, have been used for many years with initial human applications, new products on development in both areas might open new perspectives for more focused use in patients with T1DM. Physical-chemical properties and material engineering of these devices are critically reviewed to assess where we actually stand and where the future expansion of these technologies may go.

Indexed as

Immunosuppression TherapyAnimalsDiabetes Mellitus, Type 1HumansIslets of Langerhans Transplantation

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.